Rare disease care requires collaboration across families, providers, hubs, biopharma partners and specialty pharmacy. This article explores why coordinated support is essential and how specialty pharmacy helps simplify complex, unfamiliar care journeys.
Learn how Agios Pharmaceuticals partners with Biologics to deliver patient‑focused support that strengthens rare disease care. In this video, John Scott explains how coordinated hub services, specialty pharmacy collaboration, and proactive adherence support help ensure patients receive timely access to therapy and a smoother treatment journey.
This whitepaper explores the critical role of specialty pharmacy in rare disease care—addressing challenges faced by patients, providers, and biopharma. Learn how Biologics by McKesson applies decades of experience and specialized capabilities to improve access, support adherence, and streamline complex treatment journeys
Discover how Biologics protects patient-centered care during anticipated events and unplanned disruptions. Learn how proactive planning, rapid assessment, and seamless coordination kept patients connected to life-saving therapies during crises like the Change Healthcare outage and hurricanes.
In 2015, Erica was diagnosed with ovarian cancer. But when it came to working with Biologics to get her oral therapy, "It was painless," she says. "Once they received the information from my doctor, they reached out to me, and they handled everything."
Rare disease care requires collaboration across families, providers, hubs, biopharma partners and specialty pharmacy. This article explores why coordinated support is essential and how specialty pharmacy helps simplify complex, unfamiliar care journeys.
This whitepaper explores the critical role of specialty pharmacy in rare disease care—addressing challenges faced by patients, providers, and biopharma. Learn how Biologics by McKesson applies decades of experience and specialized capabilities to improve access, support adherence, and streamline complex treatment journeys
Discover how Biologics protects patient-centered care during anticipated events and unplanned disruptions. Learn how proactive planning, rapid assessment, and seamless coordination kept patients connected to life-saving therapies during crises like the Change Healthcare outage and hurricanes.
Learn how Agios Pharmaceuticals partners with Biologics to deliver patient‑focused support that strengthens rare disease care. In this video, John Scott explains how coordinated hub services, specialty pharmacy collaboration, and proactive adherence support help ensure patients receive timely access to therapy and a smoother treatment journey.
In 2015, Erica was diagnosed with ovarian cancer. But when it came to working with Biologics to get her oral therapy, "It was painless," she says. "Once they received the information from my doctor, they reached out to me, and they handled everything."
Risk-Based Care in Action: A Patient’s Journey with Personalized Support
In this video, Daniel Weaver explains Biologics by McKesson’s Risk-Based Care program and how it helps patients receive tailored support. Then, patient Dan W. shares his personal experience and the compassionate care he received from nurse Porscha throughout his treatment journey.
Patients have questions, concerns, and fears--and we're here to talk them through all of it. Our phenomenal Care Teams ensure patients are heard, educated, and set up for the best possible outcome.
